<DOC>
	<DOC>NCT00488189</DOC>
	<brief_summary>This is an antibiotic intervention study to determine the value of using piperacillin/tazobactam in reducing the cases of ESBL producing E. coli or K. pneumoniae colonization and infection.</brief_summary>
	<brief_title>Study Evaluation Tazocin Intervention</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Piperacillin, tazobactam drug combination</mesh_term>
	<criteria>All patients admitted or transferred to ICU/Pulmonary units Patients of either sex, 18 years of age or older Patients who stay in units less than 48 hours will not be enrolled.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>